Business
Notice of Results
Abingdon Health plc has announced that it will release its interim results for the six months ending 31 December 2025 on Tuesday, 17 March 2026, and will host an investor presentation on the same day at 11:00 GMT via the Investor Meet Company platform. Disclaimer*
About this update from Abingdon Health Plc
[{"type":"text","content":"\n\n \n\n \nAbingdon Health plc\n(\"Abingdon Health\", the \"Group\" or the \"Company\")\n \nNotice of Results\nInvestor Presentation\n \nYork, U.K. 5 March 2026: Abingdon Health plc (AIM: ABDX), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, will announce its interim results for the six months ended 31 December 2025 on Tuesday 17 March 2026.\n \nInvestor Presentation\nThe Company will provide a live online presentation relating to the interim results via the Investor Meet Company platform on Tuesday 17 March 2026 at 11:00 GMT. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 GMT the day before the meeting or at any time during the live presentation.\n \nInvestors can sign up to Investor Meet Company for free and add to meet Abingdon Health plc via: https://www.investormeetcompany.com/abingdon-health-plc/register-investor\n \nInvestors who already follow Abingdon Health plc on the Investor Meet Company platform will automatically be invited.\n \nEnquiries:\n \n\n\n\n\nAbingdon Health plc\n\n\nwww.abingdonhealth.com/investors/\n\n\n\n\nChris Hand, Executive Chairman\n \n\n\nVia Walbrook PR\n\n\n\n\nTom Hayes, CFO\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCavendish Capital Markets Limited (Sole Broker and Nominated Adviser)\n\n\n Tel: +44 (0)20 7220 0500\n\n\n\n\nGeoff Nash / Isaac Hooper / Joe Smith (Corporate Finance)\nNigel Birks (Life Science Specialist Sales)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR (Media & Investor Relations)\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Alice Woodings\n\n\nMob: +44 (0)7980 541 893 / +44 (0)7407 804 654\n\n\n\n\n\n\n\n\n\n\n \n\n \nAbout Abingdon Health\n \nAbingdon Health Group is a leading med-tech contract service provider offering its services to an international customer base. \n \nThe Group's CDMO (Contract Development and Manufacturing Organisation) expertise offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer ex...